Today, cerebrospinal fluid (CSF) NFL has an established position as a biomarker in the differential diagnosis between PD and atypical parkinsonism (Abdo et al., 2007; Constantinescu et al., 2010). The gene discussed is NEFL; the disease is Parkinson disease.